スカフォード技術の世界市場の規模と予測:製品別(ヒドロゲル、マイクロパターンマイクロプレート、ポリマー・ナノファイバースカフォード)、用途別、エンドユーザー別、動向分析、セグメント予測、2013-2024...市場調査レポートについてご紹介

【英文タイトル】Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2013 To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends& Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Rising demand for 3D cellular models in translational research
3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering
3.1.1.3 Technological advancement of scaffold technology
3.1.2 Market restraint analysis
3.1.2.1 Introduction of scaffold free technology for 3D cell culture
3.1.2.2 Lack of consistency in results generated
3.2 Penetration & Growth Prospect Mapping For Product, 2015
3.3 Scaffold Technology – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Market Categorization 1: Product Estimates & Trend Analysis
4.1 Scaffold technology market: Product movement analysis
4.2 Hydrogels
4.2.1 Global hydrogels based scaffold technology market, 2013 – 2024 (USD Million)
4.3 Polymeric Scaffolds
4.3.1 Global polymeric scaffolds market, 2013 – 2024 (USD Million)
4.4 Micropatterned Surface Microplates
4.4.1 Global micropatterned surface microplates market, 2013 – 2024 (USD Million)
4.5 Nanofiber Scaffolds
4.5.1 Global nanofiber scaffolds market, 2013 – 2024 (USD Million)
Chapter 5 Market Categorization 2: Application Estimates & Trend Analysis
5.1 Scaffold Technology Market: Application Movement Analysis
5.2 Cancer
5.2.1 Global cancer market, 2013 – 2024 (USD Million)
5.3 Tissue Engineering & Clinical Applications
5.3.1 Global tissue engineering & clinical applications market, 2013 – 2024 (USD Million)
5.4 Drug Development
5.4.1 Global drug development market, 2013 – 2024 (USD Million)
5.5 Stem Cell Research
5.5.1 Global stem cell research market, 2013 – 2024 (USD Million)
5.6 Others
5.6.1 Global other applications market, 2013 – 2024 (USD Million)
Chapter 6 Market Categorization 3: End use Estimates & Trend Analysis
6.1 Scaffold Technology Market: End-use Movement Analysis
6.2 Biotechnology and Pharmaceutical Industries
6.2.1 Global biotechnology and pharmaceutical organizations market, 2013 – 2024 (USD Million)
6.3 Research laboratories and Institutes
6.3.1 Global research laboratories and institutes market, 2013 – 2024 (USD Million)
6.4 Hospitals and Diagnostic Centers
6.4.1 Global hospitals and diagnostic centers market, 2013 – 2024 (USD Million)
6.5 Others
6.5.1 Global other end-uses market, 2013 – 2024 (USD Million)
Chapter 7 Market Categorization 4: Regional Estimates & Trend Analysis, by Product & Application
7.1 Scaffold Technology Market Share By Region, 2015 & 2024
7.2 North America
7.2.1 North America scaffold technology market, 2013 – 2024 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S scaffold technology culture market, 2013 – 2024 (USD Million)
7.2.3 Canada
7.2.3.1 Canada scaffold technology market, 2013 – 2024 (USD Million)
7.3 Europe
7.3.1 Europe scaffold technology market, 2013 – 2024 (USD Million)
7.3.2 Germany
7.3.2.1 Germany scaffold technology market, 2013 – 2024 (USD Million)
7.3.3 UK
7.3.3.1 UK scaffold technology market, 2013 – 2024 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific scaffold technology market, 2013 – 2024 (USD Million)
7.4.2 Japan
7.4.2.1 Japan scaffold technology market, 2013 – 2024 (USD Million)
7.4.3 China
7.4.3.1 China scaffold technology market, 2013 – 2024 (USD Million)
7.5 Latin America
7.5.1 Latin America scaffold technology market, 2013 – 2024 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil scaffold technology market, 2013 – 2024 (USD Million)
7.6 Middle East & Africa
7.6.1 Middle East & Africa scaffold technology market, 2013 – 2024 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa 3D cell culture market, 2013 – 2024 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy framework
8.2 Market participation categorization
8.2.1 Merck KGaA Group
8.2.1.1 Company overview
8.2.1.1.1 Sigma-Aldrich Co. LLC
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 Thermo Fisher Scientific, Inc.
8.2.2.1 Company overview
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 3D Biotek LLC
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 Molecular Matrix Inc
8.2.4.1 Company overview
8.2.4.1 Financial Performance
8.2.4.2 Product benchmarking
8.2.4.3 Strategic initiatives
8.2.5 ReproCELL Europe Ltd (Reinnervate)
8.2.5.1 Company overview
8.2.5.2 Financial performance
8.2.5.3 Product benchmarking
8.2.5.4 Strategic initiatives
8.2.6 Xanofi
8.2.6.1 Company overview
8.2.6.2 Financial performance
8.2.6.3 Product benchmarking
8.2.6.4 Strategic initiatives
8.2.7 Tecan Trading AG.
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.7.4 Strategic initiatives
8.2.8 Matricel GmbH
8.2.8.1 Company overview
8.2.8.2 Financial performance
8.2.8.3 Product benchmarking
8.2.8.4 Strategic initiatives
8.2.9 Pelo Biotech GmbH
8.2.9.1 Company overview
8.2.9.2 Financial performance
8.2.9.3 Product benchmarking
8.2.9.4 Strategic initiatives
8.2.10 Corning, Inc.
8.2.10.1 Company overview
8.2.10.2 Financial performance
8.2.10.3 Product benchmarking
8.2.10.4 Strategic initiatives
8.2.11 Akron Biotech
8.2.11.1 Company overview
8.2.11.2 Financial performance
8.2.11.3 Product benchmarking
8.2.11.4 Strategic initiatives
8.2.12 4titude
8.2.12.1 Company overview
8.2.12.2 Financial performance
8.2.12.3 Product benchmarking
8.2.12.4 Strategic initiatives
8.2.13 Becton, Dickinson and Company (BD)
8.2.13.1 Company overview
8.2.13.2 Financial performance
8.2.13.3 Product benchmarking
8.2.13.4 Strategic initiatives
8.2.14 3D Biomatrix
8.2.14.1 Company overview
8.2.14.2 Financial performance
8.2.14.3 Product benchmarking
8.2.14.4 Strategic initiatives
8.2.15 Avacta Life Sciences Limited
8.2.15.1 Company overview
8.2.15.2 Financial performance
8.2.15.3 Product benchmarking
8.2.15.4 Strategic initiatives
8.2.16 Nanofiber Solutions
8.2.16.1 Company overview
8.2.16.2 Financial performance
8.2.16.3 Product benchmarking
8.2.16.4 Strategic initiatives
8.2.17 NuVasive, Inc
8.2.17.1 Company overview
8.2.17.2 Financial performance
8.2.17.3 Product benchmarking
8.2.17.4 Strategic initiatives
8.2.18 Vericel Corporation
8.2.18.1 Company overview
8.2.18.2 Financial performance
8.2.18.3 Product benchmarking
8.2.18.4 Strategic initiatives
8.2.19 Molecular Partners
8.2.19.1 Company overview
8.2.19.2 Financial performance
8.2.19.3 Product benchmarking
8.2.19.4 Strategic initiatives
8.2.20 Acelity
8.2.20.1 Company overview
8.2.20.2 Financial performance
8.2.20.3 Product benchmarking
8.2.20.4 Strategic initiatives
8.2.21 Medtronic
8.2.21.1 Company overview
8.2.21.1.1 Covidien plc
8.2.21.2 Financial performance
8.2.21.3 Product benchmarking
8.2.21.4 Strategic initiatives


【レポート販売概要】

■ タイトル:スカフォード技術の世界市場の規模と予測:製品別(ヒドロゲル、マイクロパターンマイクロプレート、ポリマー・ナノファイバースカフォード)、用途別、エンドユーザー別、動向分析、セグメント予測、2013-2024
■ 英文:Scaffold Technology Market Size & Forecast, By Product (Hydrogels, Micro-Patterned Surface Microplates, Polymeric & Nanofiber Scaffold), By Application, By End-Use And Trend Analysis From 2013 To 2024
■ 発行日:2016年11月8日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707760
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。